× click new topic to start your post

FDA Accelerated Approval for Padcev - (Enfortumab-vedotin)

1 week 3 days ago #58886 by Jack R
News from late December 2019,

FDA Approves Padcev (enfortumab vedotin-ejfv) for Locally Advanced or Metastatic Urothelial Cancer, the Most Common Type of Bladder Cancer.

Another option to look into for those of us who are not good surgical candidates. I could not join the study because of other medical problems, but it was one of two that looked promising.
Info at

Best to all,

What's with this Bleeding ? 6/2015
DX: HG Papillary & CIS
3 Years and 30 BCG/BCG+Inf
Tis CIS comes back.
BC clear as of 5/17 !
RCC found in my one & only kidney 10/17
Begin Chemo; Cisplatin and Gemzar
8/18 begin Chemo# 3
Begin year 4 with cis
2/19 Chemo #4
9/19 NED again :)
Until next scope :) :)

Please Log in or Create an account to join the conversation.

  • Not Allowed: to create new topic.
  • Not Allowed: to reply.
  • Not Allowed: to add Files.
  • Not Allowed: to edit your message.
Moderators: Cynthiaeddieksara.anne


Total Online: 0 Users and 1521 Guests 


Today Total Opened: 1 Today Total Answered: 2 Latest User: dbachtel
Yesterday Total Opened: 2 Yesterday Total Answered: 8
Total Posts: 53203 Total Subjects: 6942 Total Users: 8561
Powered by Kunena Forum